Clinical Updates in Alzheimer's Disease & Related Dementia Symposium: Alzheimer’s Disease Updates скачать в хорошем качестве

Clinical Updates in Alzheimer's Disease & Related Dementia Symposium: Alzheimer’s Disease Updates

Enduring Activity: Clinical Updates in Alzheimer's Disease and Related Dementia Symposium – Alzheimer’s Disease Updates Target Audience This activity is designed for physicians, physician assistants, advanced practice providers, nurses, and other allied health care professionals. Statement of Need Memory issues can often be overlooked in primary care unless reported by patients, leading to delayed dementia diagnosis and treatment. This activity will help providers recognize dementia as a complex condition, identify its types and symptoms, explore management options, and understand the importance of interdisciplinary teams and referrals. With over 55 million people worldwide living with dementia, addressing these gaps is crucial for improving patient outcomes. Objectives At the conclusion of this offering, the participant will be able to: Describe the diagnosis of Alzheimer's Disease with biomarker confirmation. Identify treatment goals and potential side effects of antiamyloid therapies. Faculty Gregory E. Cooper, M.D., Ph.D. Chief, Adult Neurology Medical Director, Memory Center Norton Neuroscience Institute Faculty Disclosure The speaker, Gregory Cooper, M.D., PhD, has the following relationships with ineligible companies to disclose: Eli Lilly, as a principal investigator of anti-amyloid therapies; Eisai as a principal investigator of anti-amyloid therapies. These relationships have been successfully mitigated. Planner & Moderator Disclosure The following planners of this activity have relevant relationships with ineligible companies to disclose: Rachel Hart, D.O.: Eli Lilly, faculty on speaker’s bureau for Neuroscience – Kisunla. Gregory Cooper, M.D., PhD: Eli Lilly, as a principal investigator of anti-amyloid therapies; Eisai as a principal investigator of anti-amyloid therapies. These relationships have been successfully mitigated. The other planners and moderators of this activity have no relevant relationships with ineligible companies to disclose. Commercial Support This activity has not received commercial support. Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Credits Norton Healthcare Institute for Education & Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing professional development activity has been approved for 0.75 contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance. For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org. Date of Original Release | July 13, 2025 Course Termination Date | July 2027 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org Evaluation https://www.surveymonkey.com/r/Alzhei... Resources